Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Oct 26 2025
Jul 19 2025
Jan 30 2026
Nov 26 2025
Jan 22 2026